PUBLICATIONS

Clinical Research Focus. 17th Edition The Pros and Cons of the FDAs Real-Time Oncology Review Program The FDA’s Real-Time Oncology Review (RTOR) is a novel program designed to expedite the review of new cancer therapies. Since its inception the program has gained considerable attention among biotech professionals, especially those working in the field of oncology. Under the RTOR program, the FDA accepts Read more

Clinical Trials in the Baltic States – Countries’ Profile for 2023 In recent years the Baltic States, comprised of Estonia, Latvia and Lithuania, have become a formidable destination for conducting clinical trials due to its mature healthcare systems and rational regulatory reforms. On the one hand, the Baltic states abide by the same international standards and agreements as other EU countries, and, on the other, the Read more

The Pros and Cons of the FDA’s Real-Time Oncology Review Program The FDA’s Real-Time Oncology Review (RTOR) is a novel program designed to expedite the review of new cancer therapies. Since its inception the program has gained considerable attention among biotech professionals, especially those working in the field of oncology. Under the RTOR program, the FDA accepts data from clinical trials in real-time and reviews them Read more

Clinical Research Focus. 16th Edition Clinical Trials in Hungary Hungary is known for its well-developed regulatory environment and advanced healthcare system. This has made the country a popular destination for pharmaceutical companies and contract research organizations (CROs) to conduct their clinical trials. Aligned with the European Union regulations, the approval process for clinical trials is streamlined and efficient, significantly reducing Read more